NM_020822.3:c.1725C>T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_020822.3(KCNT1):​c.1725C>T​(p.Tyr575Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,613,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

KCNT1
NM_020822.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.121

Publications

0 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 9-135770403-C-T is Benign according to our data. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135770403-C-T is described in CliVar as Likely_benign. Clinvar id is 386463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.121 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000129 (188/1460858) while in subpopulation MID AF = 0.00104 (6/5766). AF 95% confidence interval is 0.000453. There are 0 homozygotes in GnomAdExome4. There are 95 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNT1NM_020822.3 linkc.1725C>T p.Tyr575Tyr synonymous_variant Exon 17 of 31 ENST00000371757.7 NP_065873.2 Q5JUK3-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNT1ENST00000371757.7 linkc.1725C>T p.Tyr575Tyr synonymous_variant Exon 17 of 31 1 NM_020822.3 ENSP00000360822.2 Q5JUK3-3

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152200
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000152
AC:
38
AN:
250604
AF XY:
0.000207
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000150
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000129
AC:
188
AN:
1460858
Hom.:
0
Cov.:
31
AF XY:
0.000131
AC XY:
95
AN XY:
726784
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33468
American (AMR)
AF:
0.000157
AC:
7
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26082
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.000522
AC:
45
AN:
86226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52892
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
0.000107
AC:
119
AN:
1111696
Other (OTH)
AF:
0.000166
AC:
10
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152200
Hom.:
0
Cov.:
34
AF XY:
0.000108
AC XY:
8
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41438
American (AMR)
AF:
0.000131
AC:
2
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68032
Other (OTH)
AF:
0.000956
AC:
2
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000114
Hom.:
0
Bravo
AF:
0.0000680
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

Significance: Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Aug 31, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Dec 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Dec 22, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 14 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KCNT1: BP4, BP7 -

Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
11
DANN
Benign
0.96
PhyloP100
0.12
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373520472; hg19: chr9-138662249; API